A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
DBV Technologies S.A.
DBVT
$3.8B
Mkt Cap
$13.63
-1.66%
DBV Technologies S.A. (DBVT) has a 5-year average return on invested capital (ROIC) of -91.7%. This is below average and may indicate limited pricing power.
DBV Technologies S.A. (DBVT) has a market capitalization of $4.0B. It is classified as a mid-cap stock.
DBV Technologies S.A. (DBVT) does not currently pay a regular dividend.
DBV Technologies S.A. (DBVT) operates in the Biological Products, (No Diagnostic Substances) industry, within the Healthcare sector.
DBV Technologies S.A. (DBVT) generated $-122 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
DBV Technologies S.A. (DBVT) has a debt-to-equity ratio of 0.04. This indicates a conservatively financed balance sheet.
DBV Technologies S.A. (DBVT) reported earnings per share (EPS) of $-0.53 in its most recent fiscal year.
Item 1. Business. DBV Technologies is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. Our therapeutic approach is based on epicutaneous immunotherapy, or EPIT, our proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). We have generated significant data demonstrating that Viaskin’s mechanism of action is novel and differentiated. Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node in order to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 5.8M | 0 | - | - | - | - |
| Net Income | -167M | -147M | -114M | -73M | -96M | -98M |
| EPS | $-0.90 | $-0.53 | $-0.59 | $-0.38 | $-0.62 | $-0.45 |
| Free Cash Flow | -152M | -122M | -107M | -80M | -56M | -109M |
| ROIC | -49.9% | -149.8% | -136.0% | -43.5% | -65.5% | -63.8% |
| Gross Margin | - | 0.0% | - | - | - | - |
| Debt/Equity | 0.00 | 0.04 | 0.25 | 0.04 | 0.01 | 0.11 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | -168M | -147M | -117M | -76M | -97M | -99M |
| Operating Margin | -2910.9% | 0.0% | - | - | - | - |
| ROE | -80.6% | -149.8% | -136.0% | -43.5% | -65.6% | -64.2% |
| Shares Outstanding | 296M | 280M | 195M | 191M | 155M | 220M |
| Metric | 2015 | 2016 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 5.8M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | N/A |
| R&D | 34M | 79M | 105M | 107M | 115M | 102M | 70M | 76M | 60M | 89M | 117M | 129M |
| SG&A | 17M | 35M | 36M | 41M | 44M | 35M | 31M | 24M | 30M | 29M | 33M | 38M |
| EBIT | 6.2M | -116M | -145M | -166M | -171M | -159M | -99M | -97M | -76M | -117M | -147M | -168M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | -2910.9% |
| Net Income | -46M | -116M | -145M | -166M | -172M | -160M | -98M | -96M | -73M | -114M | -147M | -167M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | -2895.9% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 24M | 0 | 0 | 0 | 1.4M | 16M | 16M |
| Returns on Capital | ||||||||||||
| ROIC | 2.8% | -47.8% | -88.2% | -108.3% | -102.5% | -79.7% | -63.8% | -65.5% | -43.5% | -136.0% | -149.8% | -49.9% |
| ROE | -20.8% | -41.1% | -77.8% | -132.3% | -103.6% | -80.0% | -64.2% | -65.6% | -43.5% | -136.0% | -149.8% | -80.6% |
| ROA | -13.3% | -40.4% | -81.5% | -95.1% | -77.6% | -58.7% | -46.7% | -49.0% | -33.9% | -91.6% | -98.2% | -62.9% |
| Cash Flow | ||||||||||||
| Op. Cash Flow | -27M | -60M | -114M | -137M | -148M | -166M | -108M | -56M | -80M | -104M | -121M | -151M |
| Free Cash Flow | -31M | -68M | -122M | -141M | -154M | -168M | -109M | -56M | -80M | -107M | -122M | -152M |
| Owner Earnings | -27M | -60M | -114M | -137M | -177M | -171M | -116M | -63M | -89M | -112M | -130M | -160M |
| CapEx | 4.4M | 8.0M | 7.2M | 4.7M | 5.6M | 2.8M | 910K | 754K | 677K | 2.3M | 532K | 922K |
| Maint. CapEx | 0 | 0 | 0 | 0 | 11M | 4.4M | 4.4M | 2.7M | 3.6M | 2.7M | 3.0M | 3.0M |
| Growth CapEx | N/A | N/A | N/A | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 0 | 0 | 0 | 0 | 11M | 4.4M | 4.4M | 2.7M | 3.6M | 2.7M | 3.0M | 3.0M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | 17M | 1.1M | 3.1M | 5.0M | 6.0M | 4.6M | 5.4M | 6.0M |
| Debt Repayment | 192K | 275K | 578K | 1.8M | 1.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||||||||
| Net Debt | N/A | N/A | N/A | N/A | -166M | -181M | -67M | -207M | -136M | -26M | -188M | -229M |
| Cash & Equiv. | 323M | 256M | 138M | 123M | 193M | 196M | 77M | 209M | 141M | 32M | 194M | 229M |
| Long-Term Debt | N/A | N/A | N/A | N/A | 648K | 1.3M | 510K | -474K | 0 | N/A | N/A | N/A |
| Debt/Equity | 0.07 | 0.18 | 0.37 | 0.42 | 0.14 | 0.08 | 0.11 | 0.01 | 0.04 | 0.25 | 0.04 | 0.00 |
| Interest Coverage | 42.2 | -7251.9 | -43.6 | -473.5 | -7126.0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 322M | 243M | 130M | 121M | 193M | 205M | 99M | 194M | 140M | 27M | 169M | 208M |
| Total Assets | 343M | 288M | 178M | 172M | 272M | 272M | 147M | 247M | 183M | 66M | 234M | 266M |
| Total Liabilities | 21M | 45M | 48M | 50M | 79M | 67M | 47M | 52M | 43M | 38M | 65M | 58M |
| Intangibles | 94K | 96K | 123K | 29K | 48K | 41K | 22K | 10K | 58K | 40K | 22K | 100K |
| Retained Earnings | N/A | N/A | N/A | N/A | -799M | -959M | -259M | -260M | -239M | -286M | -393M | -441M |
| Working Capital | 319M | 243M | 121M | 102M | 151M | 155M | 83M | 194M | 122M | 13M | 155M | 195M |
| Current Assets | 335M | 272M | 157M | 145M | 205M | 207M | 114M | 223M | 159M | 44M | 213M | 247M |
| Current Liabilities | 16M | 29M | 36M | 44M | 54M | 53M | 31M | 30M | 37M | 31M | 58M | 52M |
| Per Share Data | ||||||||||||
| EPS | -4.16 | -9.36 | -11.94 | -11.48 | -1.16 | -0.74 | -0.45 | -0.62 | -0.38 | -0.59 | -0.53 | -0.90 |
| Owner EPS | -2.44 | -4.80 | -9.41 | -9.44 | -1.19 | -0.79 | -0.53 | -0.41 | -0.47 | -0.57 | -0.46 | -0.54 |
| Book Value | 29.42 | 19.59 | 10.70 | 8.38 | 1.31 | 0.95 | 0.45 | 1.25 | 0.73 | 0.14 | 0.60 | 0.70 |
| Cash Flow/Share | -2.44 | -4.80 | -9.41 | -9.44 | -1.00 | -0.77 | -0.49 | -0.36 | -0.42 | -0.54 | -0.43 | -0.56 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 10.9M | 12.4M | 12.1M | 14.5M | 148.0M | 216.3M | 219.8M | 155.3M | 191.4M | 194.7M | 279.9M | 296.0M |
| Valuation | ||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -15.2 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 2.4 | 3.5 | 4.6 | 1.4 | 4.1 | 1.3 | 1.8 | 1.2 | 1.4 | 11.3 | N/A | 19.4 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 697.7 |
| FCF Yield | -4.0% | -8.0% | -20.5% | -84.9% | -19.3% | -61.3% | -60.2% | -25.1% | -42.4% | -34.4% | N/A | -3.8% |
| Market Cap | 780M | 848M | 593M | 166M | 799M | 275M | 181M | 225M | 189M | 310M | 0 | 4.0B |
| Avg. Price | 61.90 | 65.69 | 70.57 | 41.44 | 16.97 | 9.66 | 9.90 | 3.49 | 2.92 | 1.33 | 0.00 | 13.63 |
| Year-End Price | 71.24 | 68.40 | 48.86 | 11.50 | 21.60 | 5.08 | 3.30 | 2.90 | 1.98 | 3.18 | 0.00 | 13.63 |
DBV Technologies S.A. passes 0 of 9 quality checks, indicating weak fundamentals.
DBV Technologies S.A. (DBVT) has a return on equity (ROE) of -149.8%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 11 years of financial data for DBV Technologies S.A. (DBVT), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
DBV Technologies S.A. (DBVT) has a book value per share of $0.60, based on its most recent annual SEC filing.